Clinical Trial Site

Winnipeg R2V 3M3

0 studies enrolling now · 1 studies all time

What they study most

High Cardiovascular Risk, Hypertension

Studies at this site

• Zilebesiran as Add-on Therapy in Patients With High Cardiovascular Risk and Hypertension Not Adequately Controlled by Standard of Care Antihypertensive Medications (KARDIA-3) — Completed